Table 1:
Populations | Software | SNP | ChrX Position * | A1/A2 | P_JP | P_CH | P_CAN | P_ITA | P_UK | P_meta | OR [95% CI] | Locus |
ALL COHORTS | MR-MEGA | rs2239452 | 48775572 | G/C | 7.51e-06 | 5.41e-04 | 0.97 | 0.59 | 0.012 | 9.9e-08 | 1.17 [1.09–1.26] | PIM2 |
FEMALES-ALL COHORTS | MR-MEGA | rs2239452 | 48775572 | G/C | 4.35e-05 | 4.83e-4 | 0.48 | 0.36 | 5.11e-3 | 1.3e-05 | 1.11 [1.02–1.21] | PIM2 |
MALES-ALL COHORTS | MR-MEGA | rs201130692 | 132978723 | -/A | 0.015 | 0.88 | 5e-04 | 0.045 | 0.25 | 3.1e-05 | 3.16 [1.8–5.42] | GPC3 |
P_JP | P_CH | P_meta | OR [95% CI] | Locus | ||||||||
EAST ASIANS | META INTER | rs7059064 | 48837087 | G/A | 8.1e-06 | 1.75e-04 | 6.2e-09 | 1.33 [1.21–1.46] | GRIPAP1 | |||
EAST-ASIAN FEMALES | META INTER | rs2283734 | 8773556 | A/G | 4.15e-05 | 2.91e-04 | 4.64e-08 | 1.38 [1.23–1.56] | PIM2 | |||
EAST-ASIAN MALES | META INTER | rs113885580 | 38236645 | G/A | 0.0075 | 3.84e-04 | 1.06e-05 | 2.36 [1.61–3.46] | OTC | |||
P_CAN | P_ITA | P_UK | P_meta | OR [95% CI] | Locus | |||||||
CAUCASIANS | META INTER | rs62604490 | 116104694 | G/A | 0.36 | 0.0058 | 6.90e-05 | 2.98e-06 | 0.75 [0.66–0.85] | Intergenic | ||
CAUCASIAN FEMALES | META INTER | rs62604490 | 116104694 | G/A | 0.47 | 7.59e-04 | 1.09e-04 | 4.24e-06 | 0.73 [0.63–0.83] | Intergenic |
Only top signals of each suggestively/genome-wide associated region is reported (see also Figure 2).
For all SNPs presented in this table, directions among cohorts were always consistent, except for rs2239452 (all cohort analysis).
A1: tested allele (MAF allele). JP, Japanese; CH, Chinese; CAN, Canadians; ITA, Italians; UK, British; OR, odds ratio; CI, confidence interval.
According to human genome release Feb. 2009, GRCh37/hg19.